The vast majority of thyroid cancers of follicular origin (TC) have a very favourable outcome,
but 5–10% of cases will develop metastatic disease. Around 60–70% of this subset, hence …

Thyroid cancer is a frequently encountered endocrine malignancy. Despite the favorable
prognosis of this disease, 15–20% of differentiated thyroid cancer (DTC) cases and most …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …

Background: Anaplastic thyroid carcinoma (ATC) is nearly always fatal. Large studies on
ATC are exceedingly rare. We aimed to study the clinical, genotypic, and histologic …

Aims We aimed to study the clinicopathological and molecular features of high‐grade non‐
anaplastic thyroid carcinomas (HGTCs), a carcinoma with a prognosis intermediate between …

Thyroid carcinoma is the most common cancer in the endocrine system. Recent advances,
using next-generation sequencing, have shed light on the molecular pathogenesis of thyroid …

This article reviews the small percentage of thyroid tumours that are not classified as classic
papillary thyroid carcinoma, follicular thyroid carcinoma, and medullary thyroid carcinoma. It …

Background: Patients with anaplastic thyroid cancer (ATC) have a dismal prognosis, despite
systemic cytotoxic chemotherapy. The objective of this study was to investigate the efficacy …

Background Reactivation of telomerase reverse transcriptase (TERT) is an important event
in cancer. Two hotspot mutations in the TERT promoter region, c.‐124C> T (C228T) and c …

Anaplastic thyroid carcinoma (ATC) is a highly aggressive form of thyroid cancer. A single-
institution thyroid cancer cohort of ATC was identified within the last 10 years at our …